NCT07529808 2026-04-15
ChefHat-001
BigHat Biosciences, Inc.
Phase 1/2 Not yet recruiting
Clinical Trials
157 trialsNCT07518147 2026-04-08
A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
NCT07515625 2026-04-07
Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma
Fudan University
Phase 2 Not yet recruiting
NCT07510867 2026-04-06
18F-FAPI PET/CT and MRI in Gastric Cancer
First Affiliated Hospital of Zhejiang University
Not yet recruiting
NCT07511894 2026-04-06
BBNIGC
Nanfang Hospital, Southern Medical University
Phase 2 Not yet recruiting
NCT07509008 2026-04-03
Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
M.D. Anderson Cancer Center
Phase 1/2 Not yet recruiting
NCT07507071 2026-04-02
pCLE
Changhai Hospital
Not yet recruiting
NCT07507916 2026-04-02
Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma
Fudan University
Phase 2 Not yet recruiting
NCT07101666 2026-03-31
TNT-SHORT
Washington University School of Medicine
Phase 2 Not yet recruiting
NCT06828588 2026-03-30
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07502027 2026-03-30
A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma
Huazhong University of Science and Technology
Phase 4 Not yet recruiting
NCT07312370 2026-03-23
ESUS-ESD
LanZhou University
Phase 4 Not yet recruiting
NCT07486518 2026-03-20
IND-PREP
Asian Institute of Gastroenterology, India
Not yet recruiting
NCT07481357 2026-03-18
A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma
Dong-A ST Co., Ltd.
Phase 1 Not yet recruiting
NCT07467174 2026-03-12
REPROG-RCT
Yonsei University
Phase 4 Not yet recruiting
NCT07453394 2026-03-06
QLS5132 Combination Therapy in Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07452471 2026-03-05
TAP-WELPASS
Pusan National University Yangsan Hospital
Phase NA Not yet recruiting
NCT07446049 2026-03-03
A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd.
Phase 2 Not yet recruiting
NCT07401303 2026-02-27
Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time
Xijing Hospital of Digestive Diseases
Phase NA Not yet recruiting
NCT06943794 2026-02-25
Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial
Fudan University
Phase NA Not yet recruiting
NCT07401199 2026-02-10
Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)
Hebei Medical University
Not yet recruiting
NCT07391826 2026-02-06
Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting
NCT07374250 2026-01-28
Huaxi
Sichuan University
Phase 2 Not yet recruiting
NCT07365124 2026-01-26
MRinRT
Swansea Bay University Health Board
Not yet recruiting
NCT07364422 2026-01-23
To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer
Onconic Therapeutics Inc.
Phase 1/2 Not yet recruiting
NCT07358884 2026-01-22
First in Human Study of QLS5316 in Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT07351474 2026-01-20
Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy
The First Affiliated Hospital with Nanjing Medical University
Phase NA Not yet recruiting
NCT07341737 2026-01-15
SL-28 for Advanced Solid Tumours
Second Life Therapeutics
Phase 1/2 Not yet recruiting
NCT07331454 2026-01-12
Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 3 Not yet recruiting
NCT07332104 2026-01-12
The Application of Extracellular Vesicle Detection in Gastric Juice Based on Metamaterial Sensing in the Diagnosis of Gastric Cancer and Related Diseases
Beijing Friendship Hospital
Not yet recruiting
NCT07333573 2026-01-12
A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer
Shanghai Zhongshan Hospital
Phase 1/2 Not yet recruiting
NCT07333820 2026-01-12
Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201
Yonsei University
Phase 1 Not yet recruiting
NCT07323186 2026-01-07
NEOTOGAS
Nantes University Hospital
Phase NA Not yet recruiting
NCT07314203 2026-01-02
SOP-XH-IRB
Fujian Medical University
Phase 3 Not yet recruiting
NCT07314554 2026-01-02
RAGIP
LanZhou University
Not yet recruiting
NCT07315035 2026-01-02
QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting
NCT07295002 2025-12-19
Co-SNARE
Region Stockholm
Phase NA Not yet recruiting
NCT06093425 2025-12-17
Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma
Suzhou Transcenta Therapeutics Co., Ltd.
Phase 3 Not yet recruiting
NCT07276854 2025-12-11
Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue
Nanfang Hospital, Southern Medical University
Not yet recruiting
NCT07268469 2025-12-05
IMRD
European Institute of Oncology
Phase NA Not yet recruiting
NCT07260461 2025-12-03
The Efficacy and Safety of Laparoscopic Proximal Gastrectomy With LPG-tbROSF Versus LTG for Localized Proximal Gastric Cancer.
First Affiliated Hospital of Wenzhou Medical University
Phase NA Not yet recruiting
NCT07241715 2025-11-21
CONVERGENCE
National University Hospital, Singapore
Phase 2/3 Not yet recruiting
NCT07237126 2025-11-19
Single-port Robotic Radical Gastrectomy for Gastric Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase NA Not yet recruiting
NCT07219238 2025-10-21
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
GE Healthcare
Phase 2/3 Not yet recruiting
NCT02968069 2025-10-02
A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions
Shanghai Jiao Tong University School of Medicine
Phase NA Not yet recruiting
NCT07201857 2025-10-01
Peri-habilitation for Patients With Gastric Cancer
Korea University Anam Hospital
Phase NA Not yet recruiting
NCT07183358 2025-09-19
Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric Cancer
The Affiliated Hospital of Qingdao University
Phase NA Not yet recruiting
NCT07172503 2025-09-15
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase NA Not yet recruiting
NCT07139587 2025-09-10
The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Hebei General Hospital
Phase NA Not yet recruiting
NCT07166263 2025-09-10
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting